Correction: Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423479/
https://www.ncbi.nlm.nih.gov/pubmed/37402489
http://dx.doi.org/10.1136/ard-2022-223595corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423479/
https://www.ncbi.nlm.nih.gov/pubmed/37402489
http://dx.doi.org/10.1136/ard-2022-223595corr1

Ejemplares similares